.
2017
24-26 October
About Lisbon Addictions 2017
Practical information including directions to the venue (PDF)
Lisbon Addictions 2017, the second European Conference on Addictive Behaviours and Dependencies, is a multidisciplinary conference that provides a forum for networking across the addictions.
Over 600 participants from 58 countries attended Lisbon Addictions 2015. The conference sold out several months before the event. See presentations and posters
Once again, the conference will be jointly organised by the Portuguese General Directorate for Intervention on Addictive Behaviours and Dependencies (SICAD), the journal Addiction, the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) and the International Society of Addiction Journal Editors (ISAJE).
Press release
(19 July 2017) Lisbon hosts Second European conference on addictive behaviours and dependencies (PDF) — English, Portuguese
Programme
Download programme (PDF) – Last update 18.10.17
Guidelines for presenters and chairs (PDF)
The programme is organised/developed around plenary sessions, oral presentations in open sessions, structured sessions (symposia/panel discussions/workshops) and poster presentations. Sessions are scheduled in different time slots commencing Tuesday 24 October and closing on Thursday 26 October. All participants should ensure their availability for all time slots.
Keynote speakers and chairs
.jpg)
Marie Claire Van Hout
Professor of Public Health Policy and Practice, Public Health Institute, Liverpool John Moore's University, UK
Presentations
You can find below a calendar of drug-related events around the world, including conferences, exhibitions, visits to the EMCDDA and internal meetings. New events are added as information becomes available.
| Title of presentation | Author |
|---|---|
| Science & policy: what challenges face researchers and clinicians? | Henrietta Bowden-Jones |
| Translating science into policy-making in the field of drug use in developing countries | Jallal Toufiq |
| Knowledge-based policies | Alexandre Quintanilha |
| Title of presentation | Author |
|---|---|
| Law of Alcohol – Two sides of the coin: consumers and retailers | Elsa Lavado |
| Alcohol marketing: how to regulate? A comparative analysis | Marieke Vlaemynck |
| Attitudes towards alcohol policy across Europe – results of the RARHA SEAS study | Jacek Moskalewicz |
| Alcohol marketing in Portugal: alcohol industry and government strategies in the 21st century | Hilson Cunha Filho |
| Title of presentation | Author |
|---|---|
| Measuring problematic cannabis use in the general population: conception, use and future of the cannabis abuse screening test (CAST) | Stéphane Legleye |
| Changes in cultural patterns of drugs use throughout three generations of the Portuguese population – 1950,1975 and 2000 | Casimiro Balsa |
| Cannabis epidemic or return of opoid problems or decrease of high risk drug use among young adults in Austria | Martin Busch |
| Longitudinal trajectories of polydrug use among adolescents: Two-year follow-up | Martínez-Loredo, V. |
| Treatment demand indicator: experience of its implementation in Nigeria | Dominique Lopez |
| Title of presentation | Author |
|---|---|
| Problem Gambling in Adolescence: an Analysis Conducted from the Actor’s Perspective | Annie-Claude Savard |
| Title of presentation | Author |
|---|---|
| A transdiagnostic dimensional approach towards a neurocognitive assessment for addiction: An international Delphi consensus study | Prof. Murat Yücel |
| Putting the brain in its place | Susanne Uusitalo; Jaakko Kuorikoski |
| 'Nonproblematic' illicit drug use: a less known but not less important phenomenon | Olga Souza Cruz |
| Constructing alcohol-related problems – attitudes of social workers and their clients | Elina Renko |
| Title of presentation | Author |
|---|---|
| Mind-reading impairment in crack- cocaine users: a fMRI study with effects of early life stress | Rodrigo Grassi-Oliveira |
| Methamphetamine use and social cognition | Antonio Verdejo-Garcia |
| Emotion, alcohol and addiction | Salvatore Campanella |
| Social functioning in heroin users: deficits and treatments | Celia Morgan |
| Non-medical prescription opioid use & its impact on social cognition & social pain | Sara Liane Kroll |
| Title of presentation | Author |
|---|---|
| The EU Early Warning System 20 years of monitoring New Psychoactive Substances in Europe | Rachel Christie |
| National Drug Early Warning System (NDEWS): evolving drug early warning systems in a new world of drug production, distribution, and use | Erin Artigiani |
| Development and Activity Profiling of Synthetic Cannabinoids and Their Metabolites with a Newly Developed Bioassay. | Annelies Cannaert |
| The Value of Early-Warning Carfentanil Deaths in Europe | Helgi Danielsson |
| Title of presentation | Author |
|---|---|
| Decriminalisation Policy and the role of the CDT | Américo Gegaloto |
| Guidelines for dissuasion intervention: a health and preventive approach | Raquel Lopes |
| CDT Porto Dissuasion Intervention, Priority Groups and the Role of Stakeholders | Purificação Anjos |
| Portuguese Commissions for the Dissuasion of Drug Addiction: perspectives of indicted drug users on their role in drug use | Ludmila Carapinha |
| Drug users’ assessment of the enforcement of Portuguese drug decriminalisation law and predictors of drug use | Jorge Quintas |
| Title of presentation | Author |
|---|---|
| Using Artificial Intelligence for data synthesis & interpretation: The Human Behaviour Change Project | Susan Michie |
| Bayesian ‘multi-parameter evidence synthesis’ in addictions research | Hayley E. Jones |
| ITERATIVE CATEGORIzATION (ic): a system for improving transparency in analysing qualitative data | Joanne Neale |
| All drinking is not equal: Drinking occasions as the unit of analysis for understanding alcohol consumption | John Holmes |
| Improving replicability in addiction research | Robert West |
| Title of presentation | Author |
|---|---|
| The German new psychoactive substance law (NPSG): perceived and expected outcomes in the first stage of implementation | Tessa-Virginia Hannemann |
| NPS current health-related practices and challenges in responding to use and harms in Europe | Alessandro Pirona |
| Responses to the problem of ‘legal highs’ in Poland and their consequences | Krzysztof Krajewski |
| Title of presentation | Author |
|---|---|
| Understanding Addiction: A Health Inequalities and Social Harms Perspective | Aileen O’Gorman |
| Maternal Substance Use And Child Protection: A Rapid Evidence Assessment Of Factors Associated With Loss Of Child Care | Martha Canfield |
| Title of presentation | Author |
|---|---|
| Patient centered care for injectable opioid assisted treatment | Kirsten Marchand |
| Boxing Clever: evaluation of a community based inter-agency education and fitness substance use intervention program | Sarah Morton |
| Efficacy of case management for persons with substance use disorders: a Cochrane update | Wouter Vanderplasschen |
| Title of presentation | Author |
|---|---|
| Implications of monitoring alcohol marketing for public health and policy | Carina Ferreira-Borges |
| Evaluating the effect of full legalization on the medical cannabis market: Implications for the European Healthcare System | Davide Fortin |
| To use or not to use? An exploration of cannabis use motives and constraints | Liz Temple |
| Title of presentation | Author |
|---|---|
| The efficacy of Behavioral Activation and voucher-based Contingency Management for cigarette smokers with depression: a Randomized Controlled Trial | Alba González-Roz |
| Smoking cessation treatment and risk of longer term health outcomes in the Clinical Practice Research Datalink | Kyla Thomas |
| Predicting treatment outcome: An examination of the mechanism of action of two pre-quit smoking cessation pharmacotherapies | Stuart Ferguson |
| Title of presentation | Author |
|---|---|
| An Empirical Basis To Diagnose Gambling And Gaming Disorders | Karl Mann |
| A Comparison between National Guidelines for Treatment of Alcohol Use Disorder | Conor K Farren |
| EUFAS survey 2017 - Medical cannabis in Europe | Jørgen G. Bramness |
| Title of presentation | Author |
|---|---|
| The role of standards on quality of treatment of drug use | Lubomir Okruhlica |
| Experiences of implementation of EU Prevention Quality Standards | Harry Sumnall |
| Role of training for the implementation of quality standards and how to design assessment | Matej Košir |
| Title of presentation | Author |
|---|---|
| Reframing the gambling field: epistemological and methodological shifts and the study of the gambling/gaming convergence | Sylvia Kairouz |
| Business Models of Gaming and Gambling and how they Converge | Ingo Fiedler |
| Spectrum Model of Social Casino Gaming/Gambling: Understanding the Convergence | Jennifer Reynolds |
| Title of presentation | Author |
|---|---|
| The evolution of the opioid abuse epidemic in North America | Richard C. Dart |
| The landscape of prescription drug misuse in the UK | David M Wood |
| The Euro-Drug Emergencies Network (Euro-DEN): ED presentations with acute toxicity related to the misuse of prescription medicines | Paul I. Dargan |
| The European experience: prescription drug misuse in France, Germany, Italy and Spain | Jody L. Green |
| Title of presentation | Author |
|---|---|
| HepCheck: To enhance HCV screening of PWID | John Lambert |
| Integrating Hepatitis C Treatment in Primary Care | Walter Cullen |
| Developing a Community Peer Support model to improve access to HCV treatments for PWID | Lar Murphy |
| Title of presentation | Author |
|---|---|
| Popular promises of progress: The articulation of BDMA in the media | Anna Alanko; Matilda Hellman, |
| Diagnosing the BDMA | Jaakko Kuorikoski; Susanne Uusitalo, |
| Gambling and the brain | Janne Nikkinen |
| Title of presentation | Author |
|---|---|
| Advancing theory and treatment approaches for males in substance use treatment who perpetrate intimate partner violence | Gail Gilchrist |
| Title of presentation | Author |
|---|---|
| Relative Reinforcing Efficacy of Cigarettes among depressed and non-depressed smokers | Alba González-roz |
| The prospective association between smoking and electronic cigarette use in a cohort of young people in Great Britain | Katherine East |
| Young adults report increased pleasure from using e-cigarettes and smoking tobacco cigarettes when drinking alcohol | Johannes Thrul |
| Title of presentation | Author |
|---|---|
| Validation of alcohol consumption self-reports in the Munich Composite International Diagnostic Interview (M-CIDI) | Sören Kuitunen-Paul |
| Screening for moderate/high risk alcohol use among opioid dependent patients on buprenorphine maintenance: a clinical and alcohol-biomarker study | Suresh Thapaliya |
| Emotion regulation and cognitive control in alcohol dependence | Svetlana G. Klimanova |
| Neuropsychological performance in patients with SUD with and without mood disorders | Irma Höijer |
| Title of presentation | Author |
|---|---|
| Recidivism of female systematic offenders | Dr. Eric Blaauw |
| Predicting offending after residential rehabilitation | Birgitte Thylstrup |
| «You, of all people» Interviews with ten nurses who lost their medical license due to prescription drug use and theft from the work place | Oda Sjøvoll |
| ´If the person doesn’t drink they are one person, if they drink they are another´. How men in treatment for substance use in England and Brazil account for perpetrating intimate partner violence | Polly Radcliffe |
| Title of presentation | Author |
|---|---|
| Efficacy and safety of sofosbuvir/velpatasvir in people with chronic hepatitis C virus infection and recent injecting drug use: The SIMPLIFY study | Jason Grebely |
| Hepatitis C antibody and RNA prevalence among opiate substituted patients in Germany: Results from the nationwide ECHO-Study | Bernd Schulte |
| Associations of HIV and HCV with prison history among people who inject drugs in Europe and beyond | Lucas Wiessing |
| Modelling the Impact of Interventions Targeting High-‐‑Risk Populations on the HCV Epidemic in Resource-‐‑Limited Settings | Aaron G. Lim |
| Title of presentation | Author |
|---|---|
| Needle syringe programmes and opioid substitution therapy for prevention HCV transmission among people who inject drugs: Cochrane Systematic Review | Matthew Hickman |
| Recent incarceration and risk of hepatitis C and HIV transmission amongst people who inject drugs: A systematic review and meta-analysis | Jack Stone |
| The efficacy of psychosocial interventions to reduce sexual and drug blood borne virus risk behaviours among people who inject drugs: A systematic review and meta-analysis | Gail Gilchrist |
| Coverage of HIV and HCV prevention interventions for people who inject drugs | Sarah Larney |
| Title of presentation | Author |
|---|---|
| Evaluation of drug laws and policies by means of indicators and data regarding minor subjects, PDUs…... | Carla Rossi |
| Informing a strategic plan for children of parents who use substances within a defined community | Catherine Comiskey |
| Modeling the impact of the Mexican drug law reform on HIV incidence among people who inject drugs (PWID) in Tijuana, Mexico. | Annick Bórquez |
| UN drug agenda Post 2019 - What to expect from the UNGASS process | Danilo Ballotta |
| Title of presentation | Author |
|---|---|
| Changing patterns of new and emerging psychoactive substances in Australia | Rachel Sutherland |
| New drug use trends in Germany? | Elena Gomes de Matos |
| New Psychoactive Substances in Portugal - Trends and approaches | Susana Henriques |
| French media and new psychoactive substances: is a new discourse emerging? | Julie-Emilie Adès |
| Title of presentation | Author |
|---|---|
| Online prevention of substance abuse among students with eCHUG-D | Marion Laging |
| High School Finalists Trip: preventing risk behaviour for young people | Irma Brito |
| Understanding and intervening on addiction stigma | Karsten Lunze |
| Learning from success:The implementation and evaluation of the Israeli national program to reduce problem drinking of alcohol among children and youth 2010-2016 | Yossi Harel-Fisch |
| Title of presentation | Author |
|---|---|
| Multi-setting community-based interventions to reduce population level harms arising from alcohol and other drug use. | Emily Stockings |
| A cross-sectoral integrated care approach to addiction and homeless services: the experience from southern Ireland | Joe Kirby |
| Integrating Hepatitis C Treatment in Primary Care | Walter Cullen |
| Fast Track Opiate Agonist Treatment (OAT) for Homeless, Americans | Marcia Tanur |
| The New Privatized Market for alcohol and drug treatment – growing challenges in regard to inconsistent principles and fumbling steering models | Jessica Storbjörk |
| Title of presentation | Author |
|---|---|
| nforming an evidence-based cannabis and driving policy | Kim Wolff |
| Cannabis and driving: a case study of Colorado | Glenn Davis |
| Cannabis and driving: a case study of Washington State | Darrin Grondel |
| Cannabis and driving: a case study of the Netherlands | Jan Ramaekers |
| Title of presentation | Author |
|---|---|
| Exploring online problem gamblers' motivation to change | Ayna Johansen |
| Assessing readiness to implement web-based interventions for the prevention and/or reduction of substance use at ten universities in Germany – results of the DIOS-project | Claudia Pischke |
| Characteristics of gamblers using a national help-line for problem gambling in France between 2010 and 2015 | Stéphane Darbeda |
| YouTube presence of an addiction medicine service: what works? | Gerard Calzada |
| Title of presentation | Author |
|---|---|
| Beyond Voluntary Consent: Ethical dilemmas in a clinical trial testing the effectiveness of injectable opioid assisted treatment for long-term opioid dependence | Kirsten Marchand |
| Different modes of data collection, different results? | Clara Vital |
| The absurdity of asking people about opinions they do not yet have | Alfred Uhl |
| Ethical Inquiry into Cannabis Pilot Projects | Susanne Uusitalo |
| The use of licit and illicit drugs and the workplace: defining a model of survey questionnaire |
| Title of presentation | Author |
|---|---|
| Alteration to Hippocampal Volume and Shape Confined to Cannabis Dependence: A Multisite Study | Yann Chye |
| Locomotor sensitization to cocaine and methamphetamine in Drosophila melanogaster | Rozi Andretic Waldowski |
| Using functional near infrared spectroscopy to identify neural activity during cue-elicited in a real-life setting | Flora Colledge |
| Accumulation of Highly Stable ΔFosB-Isoforms and Its Targets inside the Reward System of Chronic Drug Abusers – A Source of Dependence-Memory and High Relapse Rate? | Monika Heidemarie Seltenhammer |
| Anabolic androgenic steroid dependence and brain structure | Lisa Evju Hauger |
| Title of presentation | Author |
|---|---|
| Is dialectical behavior therapy skills training a therapeutic alternative in alcohol use disorder and personality disorders comorbidity treatment? | Marco Cavicchioli |
| Outpatient addiction treatment for alcohol use disorder: what makes patients who dropped out different from those who did not? | Vincent Wagner |
| Effectiveness of brief intervention for moderate/high risk alcohol use among patients on buprenorphine maintenance: a clinical and alcohol-biomarker study | Suresh Thapaliya |
| Characteristics and significance of professional-led support groups in the treatment of alcoholism | Ana Opačić, Tereza Oreb |
| Title of presentation | Author |
|---|---|
| Interaction and interplay between rapid assessment (HKH) and a local monitoring system (BEWS) | Liv Flesland |
| Title of presentation | Author |
|---|---|
| Anabolic steroids: a global public health perspective | James McVeig |
| Anabolic steroid and substance use among prisoners - findings from a Norwegian national prison survey | Ingrid Havnes |
| Outline of a typology of men’s use of anabolic androgenic steroids in fitness and strength training environments | Dimitris Liokaftos |
| An investigation of cognitive functions in long-term AAS-using and non-using weightlifters | Astrid Bjørnebekk |
| Treatment and information needs among AAS users with health problems. | Christine Wisløff |
| Title of presentation | Author |
|---|---|
| Regional key findings | Elisa Benedetti |
| Drug use among Moroccan Youth: Medspad Surveys | Jallal Toufiq |
| Legal, social and economic aspects that impact on prevalence of substance use, in Tunisia | Hajer Aounallah-Skhiri |
| Prevalence of Alcohol, Tobacco and drug use among school aged children in Algeria | Salah ABDENNOURI |
| The social epidemiology of alcohol and drug use among Israeli school-aged children: Recent developments and current challenges | Yossi Harel-Fisch |
| Title of presentation | Author |
|---|---|
| ‘Drinking occasions’ as the unit of analysis for understanding alcohol consumption | Paul Toner |
| Using Artificial Intelligence for data synthesis and interpretation: The Human Behaviour Change Project. | Felix Naughton |
| Iterative categorisation (IC): a system for improving transparency in analysing qualitative data | Caitlin Notley |
| Improving replicability in addiction research | Tom Freeman |
| Title of presentation | Author |
|---|---|
| Introduction to the EU ATTUNE study: an overview of the mixed method design and its rationale | Marcus-Sebastian Martens |
| Which individual, social and environmental influences shape different pathways of amphetamine type stimulant use over the life course? | Amy O’Donnell / Michelle Addison |
| ATTUNE: Understanding Pathways To Stimulant Use A Mixed-methods Examination Of The Individual, Social And Cultural Factors Shaping Illicit Stimulant Use Across Europe | Roman Gabrhelik |
| Exploring trajectories of ATS use from life events and substance use timelines in qualitative interviews | Nienke Liebregts |
| Design, methods and instruments of the forthcoming quantitative study arm | Magdalena Rowicka |
| Title of presentation | Author |
|---|---|
| Serotoninergic biomarkers in substance dependent patients with comorbid depression | Marta Torrens |
| Changes in the serum metabolites of tryptophan in abstinent cocaine and alcohol users and their relationship with co-morbid disorders | Rebeca Vidal |
| PsyGeNET a new tool to investigate genetic targets in psychiatric disorders and drug addiction | Olga Valverde |
| Stress and neuroimmune response as biomarkers of cocaine and alcohol used disorders | Marta Rodríguez Arias |
| Acylethanolamides and chemokines as biomarkers of addiction: a link to neuroinflammation? |
| Title of presentation | Author |
|---|---|
| Addiction in daily life: mobile assessment and treatment | Ingmar Franken |
| Cognitive measures in EMA research | Andrew Jones |
| EMA Outcome Measures in a Clinical Trial | Ilse Verveer |
| Smartphone apps for the treatment of addictive disorders | Yasser Khazaal |
| Discussion: Addiction in daily life: mobile assessment and treatment | Matt Field |
| Title of presentation | Author |
|---|---|
| Expanding the global profile of people who inject drugs: Summarising recent reviews | Louisa Degenhardt |
| The Harms of Drug Supply: Why and How to Assess Them | Letizia Paoli |
| The Opioid Epidemic:HHS Response | Christopher M. Jones |
| Title of presentation | Author |
|---|---|
| Understanding the new cannabis regulatory frameworks | Ivana Obradovic |
| Are The Times A-Changin’? Trends in Adolescent Substance Use in Europe | Ludwig Kraus |
| Descriptive e-cigarette norms on tobacco attitudes and smoking behavior: The importance of close friends and peers | William D. Crano |
| Pathways to future Drug policies – the interesting case of decriminalization: a scoping review | Marta Pinto |
| A work in progress? Understanding the development and current features of the CSC model in Belgium | Mafalda Pardal |
| Title of presentation | Author |
|---|---|
| Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies | Marica Ferri |
| Rates, causes and predictors of death among drug users in France: invisibility of fatal overdoses | Anne-Claire Brisacier |
| Methamphetamine-related death in Australia: A national 7 year study | Shane Darke |
| Title of presentation | Author |
|---|---|
| Attentional bias between light and heavy drinking college students | Alexandra Ghita |
| Sensation seeking and adolescent alcohol use: exploring the mediating role of unstructured socializing with peers | Sharon Sznitman |
| Prevention of alcohol abuse in college students | Carla Adriana Rocha |
| Alcohol: raising awareness and action-research on heavy episodic drinking among low income youth and young adults in Southern Europe | Helena Carvalho |
| Associations between personal and perceived peer use and attitudes towards substance use among German university students | Stefanie Maria Helmer |
| Title of presentation | Author |
|---|---|
| Postal based harm reduction service for hard-to-reach injecting drug users | Thomas Nefau |
| Diagnosis and treatment of HCV infection: a tool of engagement for people who inject drugs (PWID) | David Truong |
| The revision of Germany’s federal legal framework for opioid substitution treatment | Kenan Maric-Horstmeyer |
| The German medical association’s revised guidelines for OST: legal framework, treatment regulations and scientific rationale | Wilfried Kunstmann |
| Towards a long-term perspective: analysis of treatment participation in opioid substitution therapy in four European regions | Carlos Nordt |
| Title of presentation | Author |
|---|---|
| “Prevalence study, ESPAD 2015” Tentative title: The role of national policies and perceived availability for the use of alcohol, cigarettes and cannabis among European students | Håkan Leifman |
| Students at Risk of Substance Use: Latent Class Risk and Protective Factor Profiles | Pavla Chomynová |
| Do misusers of medicinal psychotropic drugs form a distinctive group among the adolescent-student population in Europe? A latent class analysis | Anastasios Fotiou |
| Prevalence of youth gambling and potential influence of substance use and other risk factors in 35 countries across Europe: First results from the 2015 ESPAD study | Sabrina Molinaro |
| New psychoactive substance use in young poly substance using Europeans | Harry Sumnall |
| Title of presentation | Author |
|---|---|
| ‘New’ synthetic opioids in Europe:perspective from the EU EWS | Rita Jorge |
| Misuse of opioids in Europe | Cathy Stannard |
| The U.S. opioid epidemic: a perspective on trends and responses from the U.S. NDEWS | E. Erin Artigiani |
| The use and unintended consequences of pharmaceutical opioids in Australia? | Michael Farrell |
| Title of presentation | Author |
|---|---|
| Review of the existing European network with summary of all data, and overview of future international programs | Kevin V. Thomas |
| Comparison of data from WBE with other sources | Frederic Been |
| Detection of new psychoactive substances (NPS) use across Europe | Sara Castiglioni |
| Assessing prescription drug abuse using functional principal component analysis (FPCA) of wastewater data | Jørgen Bramness |
| Review of the uncertainties in WBE. | Christoph Ort |
| Title of presentation | Author |
|---|---|
| Capacity building and unexpected positive impact of emerging new profession of addiction specialist on preventive measures in prison system: a case study | Michal Miovsky |
| The Universal Treatment Curriculum (UTC) for Addiction Treatment Professionals | Melody M. Heaps |
| Effectiveness of Treatment Alternatives to Incarceration for Drug-Involved Persons | Roger H. Peters |
| Title of presentation | Author |
|---|---|
| European Web Survey on Drugs: patterns of use | Nicola Singleton, João Matias |
| Facebook ads as recruitment for online drug surveys: the Holy Grail? | Dijana Jerković |
| The Global Drug Survey - How online methods and independence offer alternative perspectives on drug use | Prof. Adam R. Winstock; Dr. Larissa J. Maier |
| Reliability & validity issues in European web survey in Czech Republic | Katerina Skarupova |
| Estimating cannabis demand: use of online surveys to capture use patterns | Margriet van Laar |
| Title of presentation | Author |
|---|---|
| Economic and Conflict Based Rapid Mass Population Movement into Europe: The security and public health implications for future EU drugs policy | Marie Claire Van Hout |
| Decreasing life expectancy despite gains in cancer and cardio-vascular disease mortality? The role of addictions in public health in high-income countries | Jürgen Rehm |
| Title of presentation | Author |
|---|---|
| Is misuse of benzodiazepines among high-risk drug users an overlooked public health issue? | Dominique Lopez |
| Medication use and misuse among illicit drug users in France | Aurélie Lermenier-Jeannet |
| Orienting the Appropriate Treatment of Pain in Detained Drug Users: Indications from a Retrospective Study | Felice Nava |
| Gabapentin diversion and misuse in the United States from a law enforcement perspective: Diversion rates 2002-2015 and qualitative research findings | Mance E. Buttram |
| Title of presentation | Author |
|---|---|
| New perspectives for knowledge generation and exploitation using web surveys: the example of volume estimation in wastewater epidemiology | Robin Udrisard |
| High risk drug use and NPS in Europe | Jane Mounteney |
| Online drug forum sentiment analysis | Dr. Matthijs Blankers |
| National estimation of the prevalence of problem drug use: revisiting and extending multiplier methods in a multi-parameter evidence synthesis framework | Hayley Jones |
| Development of a national wastewater drug monitoring program in Australia | Jake O’Brien |
| Title of presentation | Author |
|---|---|
| The opioid exposed infant 0-36 months | Anna Maria Vella |
| Alcohol drinking in pregnancy: some predictors among Portuguese women | Ludmila Carapinha |
| Cannabis use during pregnancy and risk of adverse neonatal outcomes: a longitudinal cohort study | Svetlana Skurtveit |
| Title of presentation | Author |
|---|---|
| Cross-sectional and longitudinal studies to determine the potential for clinically meaningful khat use disorder and withdrawal syndromes | Raimondo Bruno |
| Social profiles, drug use practices and HCV exposure of Russian-speaking migrants in France | M. Jauffret-Roustide |
| The representation of non-Belgians in national drug treatment | Eva Blomme |
| Drug consumption rooms : issues of social acceptability in French public debate | Marie Jauffret-Roustide |
| Title of presentation | Author |
|---|---|
| Mortality and causes of death in an ageing Norwegian OMT cohort | Ivar Skeie |
| Mortality during Opioid Maintenance Treatment in Norway in the years 2014 and 2015 | Anne Bech |
| Modeling the potential impact of providing ART and OAT in prison and upon release on HIV incidence among PWID in Tijuana, Mexico | Annick Bórquez |
| Opioid overdose mortality trends in Australia | Amanda Roxburgh |
| The impact of buprenorphine and methadone on mortality: a primary care cohort study in the United Kingdom | Matthew Hickman |
| Title of presentation | Author |
|---|---|
| Overdose deaths: diverging trends among heterogeneous groups of victims | Isabelle Giraudon |
| New non-injectable naloxone products: Global overview | Rebecca McDonald |
| Experiences from a national overdose prevention strategy: Nasal naloxone distribution and lessons learned | Philipp Lobmaier |
| Opt-out versus opt-in: should take-home naloxone be required as safe clinical practice? | John Strang |
| Take-home naloxone as integral part of toolkits for public health providers: priorities across settings | Dagmar Hedrich |
| Title of presentation | Author |
|---|---|
| Implicit associations in male and female gamers across different online games are linked to symptoms of Internet Gaming Disorder | Christian Laier |
| Psychological and neurobiological mechanisms underlying the addictive use of specific Internet applications | Matthias Brand |
| Implicit association and craving towards shopping cues in buying disorder | Patrick Trotzke |
| Personal responsibility rhetoric in policy responses to gambling: the views of people with lived experience of gambling addiction | Helen Miller |
| Title of presentation | Author |
|---|---|
| ASSIST+Frank: an external pilot cluster randomised control trial | James White |
| Assessment of Drug Treatment in Croatia - results from CATS (Croatian Addiction Treatment Survey) and its implication on new national Drug Policy strategy | Zrinka Ćavar |
| An approach to disinvestment in the field of drug addiction treatment | Antonella Camposeragna |
| Does exposure to opioid substitution treatment in prison reduce the risk of death after release? | Matthew Hickman |
| Title of presentation | Author |
|---|---|
| Prevalence of drug and alcohol use in somatic healthcare - A cross-sectional comparative study | Danil Gamboa |
| Estimating alcohol annual consumption on the basis of population survey | Janusz Sierosławski |
| Context Of Daily Drinking In 18 European Countries. Findings Of The RARHA SEAS Project | Katarzyna Okulicz-Kozaryn |
| Energy Drink and Alcohol mixed Energy Drink use among high school adolescents: Association with risk taking behavior, social characteristics. | Sabrina Molinaro |
| Factors Associated With Binge Drinking In Adolescence: Integrative Literature Review | Tereza Barroso |
| Title of presentation | Author |
|---|---|
| Improvement of the support of addicted persons‘ relatives | Petra Baumberger |
| Difficult-to-reach target groups in addiction aid - what efforts are already taken in Switzerland and what need for action remains? | Stefanie Knocks |
| SafeZone.ch – online counselling on addiction | Salomé Steinle |
| Title of presentation | Author |
|---|---|
| Narratives of long term recovery: understanding relational behaviour change | Jo Ashby |
| Co-productive research with substance-using communities | Lucy Webb |
| New psychoactive substances, new service provider challenges: rethinking drug user’s identities, identification and the service response | Rob Ralphs |
| Who supports dying substance users? Drug using identities and end of life care | Sarah Galvani |
| Title of presentation | Author |
|---|---|
| Health Outcomes for Clients of Needle and Syringe Programs in Prisons: A Systematic Review | Prof. Dr. Heino Stöver |
| No one gets left behind: Addressing the hidden burden of hepatitis C related advanced liver disease in PWID in the community | John S. Lambert |
| Community HIV testing in PWID: data from the COBATEST network | Laura Fernàndez-López |
| Pilot Condom Distribution in Czech Prison | Viktor Mravčík |
| Hepatitis C Testing, Care and Treatment at Harm Reduction Centres in the European Union: a 28-Country Survey of Service Providers | Prof Jeffrey V. Lazarus |
| Title of presentation | Author |
|---|---|
| Health and social responses to drug problems: a European guide | Nicola Singleton |
| Supporting implementation of effective interventions | Harry Sumnall |
| Title of presentation | Author |
|---|---|
| Definitions of risky and problematic cannabis use: a systematic review | Cristina Casajuana |
| Assessment of risky cannabis use and related consequences | Hugo López Pelayo |
| The Standard Joint Unit as a tool for assessing risky cannabis use | Antoni Gual |
| Weighing the Evidence: A Systematic Review on Long-Term Neurocognitive Effects of Cannabis Use in Abstinent Adolescents and Adults | Florian Ganzer |
| Title of presentation | Author |
|---|---|
| Extending Definitions in Addictions: Challenges and Risks | Joël Billieux |
| Challenges ahead for tobacco policies | Ann McNeill |
| Design Considerations for Legal Cannabis: The 12 P’s | Rosalie Liccardo Pacula / Beau Kilmer |
| Title of presentation | Author |
|---|---|
| Forensic drug intelligence and the rise of darknet marketplaces | Marie Morelato |
| Monitoring online activity on cryptomarkets 2013-2017 | Amanda Roxburgh |
| Monitoring online activity on cryptomarkets 2013-2017 | Amanda Roxburgh |
| THIS PLACE IS LIKE THE JUNGLE - A qualitative marketplace forum analysis | Sara Rolando |
| Drugs bought online/offline @Netherlands | Peggy van der Pol |
| Drug trade via cryptomarkets: Size, scope, trends and the role of the Netherlands | Kristy Kruithof |
| Title of presentation | Author |
|---|---|
| Gambling in Croatia | Zrinka Puharić |
| Core Gambling-Related Traits and their Relationships with Gambling Behavior Patterns and Severity: An Exploratory Study with Ecuadorian Gamblers | María F. Jara |
| Association of Problem Gambling with Type of Gambling Among the Italian General Population | Elisa Benedetti |
| Title of presentation | Author |
|---|---|
| The use of alcohol and drugs and its relation to the workplace | Claudia Urbano |
| Breaking Out of the Joint: Cognitive Bias Modification Targeting the Cannabis and Alcohol Consumption of Youth in Juvenile Detention Centers | Hans van der Baan |
| One-year sobriety improves satisfaction with life, executive functions and psychological distress among patients with polysubstance use disorder | Egon Hagen |
| Symptoms and correlates of emergency medical treatment following the use of MDMA | Larissa J. Maier |
| Title of presentation | Author |
|---|---|
| Experiential avoidance and emotional dysregulation as therapeutic dimensions in alcohol use disorder treatment | Marco Cavicchioli |
| Clinical Strategies for Engaging Families in Substance Addiction Treatment | Sebastian Perumbilly |
| Building a bridge between prevention research and practice | Maximilian von Heyden |
| Development of Therapeutic Alliance and Outcomes from the Perspective of Drug Users undergoing Treatment in a Therapeutic Community | Luís Janeiro |
| Title of presentation | Author |
|---|---|
| Insecure Attachments & Female Drug Misuse | Efrat S. Fridman |
| Treatment effectiveness of injectable hydromorphone and diacetylmorphine for severe opioid use disorder and its relationship with gender in the SALOME clinical trial | Heather Palis |
| Experiences and barriers of female substance users in alcohol and drug prevention and treatment | Julie Schamp |
| Suicidal ideation among long-term opioid users: Its Risk Factors and the role of gender | Kirsten Marchand |
| Title of presentation | Author |
|---|---|
| Promoting a new era in global training & education of addiction professionals: the International Consortium of Universities for Drug Demand Reduction | Charlotte Sisson |
| The Universal Treatment Curriculum (UTC) for Addiction Treatment Professionals | Melody Heaps |
| European academic education and training programs for addiction specialists: a Google survey and current context and coordinating centre for Europe | Michal Miovsky |
| ICUDDR and International Networking and Collaboration | Roger H. Peters |
| International Society of Substance Use Prevention and Treatment Professionals (ISSUP) | Joanna Travis-Roberts |
| Universal Prevention Curriculum | Zili Sloboda |
| Title of presentation | Author |
|---|---|
| Drug treatment expenditure: a methodological overview | Paul Griffiths |
| A methodology for estimating health expenditure on drug treatment: the Australian experience | Alison Ritter |
| Rosalie Liccardo Pacula | Rosalie Liccardo Pacula |
| A methodology for an EU cross-country comparison: public expenditure on drug treatment in hospitals | Freya Vander Laenen |
| Social cost of drugs in France | Pierre Kopp |
| Title of presentation | Author |
|---|---|
| Setting the scene of drug-related deaths in Europe: rebound and shifts? A diverse picture | Isabelle Giraudon |
| A review of drug-related deaths in seven Northern European countries | Tim Millar |
| Drug-related deaths – the Swedish case | Håkan Leifman |
| Preventing drug-related deaths: Policy implications and ways forward. Focus on Norway. | Thomas Clausen |
| Title of presentation | Author |
|---|---|
| Does OST increase pregnancy rates in substance using women? | Jan-Peter Siedentopf |
| Drug use and reproductive choices | Mary Hepburn |
| Reproductive health in treatment and recovery | Mishka Terplan |
| The opioid-dependent pregnant woman | Anna Maria Vella |
| Title of presentation | Author |
|---|---|
| Model and empirical evidence on the effectiveness of interventions to prevent HCV among people who inject drugs | Matthew Hickman |
| Direct-acting interferon-free therapies and reinfection among people who inject drugs | Jason Grebely |
| Restrictions for reimbursement of interferon-free direct-acting antiviral therapies for HCV infection in Europe | Jeffrey Lazarus |
| Title of presentation | Author |
|---|---|
| WHO minimum public health data set on prison health | Lars Moller |
| European Questionnaire on Drug Use among Prisoners - EQDP | Viktor Mravčik |
| WEPHREN | Linda Montanari |
| Drug research and drug monitoring in prison - Spanish Survey on Health and Drug use among Prisoners | Elena Alavarez |
| Monitoring drug use in custodial institutions for juvenile offenders in Portugal | Ludmila Carapinha |
| The French System of Drug Monitoring in Prisons | Marie Jauffret-Roustide |
| Title of presentation | Author |
|---|---|
| Drug use in European recreational settings: mixing contexts, risks and pleasure | João Matias |
| Environmental Prevention in Nightlife Settings | Johanna Gripenberg |
| Protecting and promoting health in nightlife environments during the last three decades | Andrew M Bennett |
| Zurich’s approach to enhance the pleasure of going out | Alexander Bücheli |
| Emerging trends within nightlife settings: responses and innovation | Sarah Morton |
| Title of presentation | Author |
|---|---|
| Drug consumption rooms in Porto, Portugal: listening to the concerned voices | Paula Meireles |
| Frequency and severity of non-fatal opioid overdoses among clients attending the Sydney Medically Supervised Injecting Centre | Amanda Roxburgh |
| Drug Consumption Rooms in Catalonia: Major impact on HIV-HCV risk behaviors and engagement in care | Cinta Folch |
| Factors Concerning Access to a Potential Drug Consumption Room in Dublin, Ireland | Emma Atkin-Brenninkmeyer |
| Title of presentation | Author |
|---|---|
| Improving Treatment Outcome By Adding Different Structural Elements To Outpatient Substance Abuse Treatment Programs Offered To Danish Youth. | Sheila Jones |
| Validation of the Portuguese DSM-IV-MR-J | Joana Alexandre |
| Evaluating the Integration of Indigenous healing practices with Principles of Seeking Safety for Treatment of Indigenous Patients with a History of Trauma and Active Substance Use Disorder | Teresa Naseba Marsh |
| The Efficacy Of Mindfulness-based Treatments For Alcohol And Drugs Use Disorders: a critical meta-analytic review of randomized and nonrandomized controlled trials | Marco Cavicchioli |
| ASSIST - Feasibility study in Primary Health care in Catalonia | Joan Colom |
| Title of presentation | Author |
|---|---|
| Cost-effectiveness of low dead space detachable syringes for the prevention of Hepatitis C | Peter Vickerman |
| Hepatitis C: Awareness Through to Treatment (HepCATT): Pilot of an intervention designed to increase diagnosis and treatment of patients with hepatitis C virus infection in drug treatment settings | Matthew Hickman |
| Health systems requirements for viral hepatitis elimination: Are we 'Flying Blind' in our efforts? | Jeffrey V. Lazarus |
| Documenting barriers to access HCV care and treatment: a peer-led research | João Santa Maria |
| SOF/VEL/VOX and Other Sofosbuvir-Based Direct-Acting Antiviral Therapies for Hepatitis C Virus in Patients Receiving Opioid Substitution Therapy: An Analysis of Phase 3 Studies | Jason Grebely |
| Title of presentation | Author |
|---|---|
| Misuse of General Population Surveys: Estimating Heroin Prevalence in the United States | Peter Reuter |
| Representativeness challenges for web surveys collecting information on drug users: a way for improving the cannabis market estimation in France. | François Beck |
| Public expenditure on drug treatment and associated comorbidities: a case study of Bergamo | Sabrina Molinaro |
| Title of presentation | Author |
|---|---|
| Traditional use of Ayahuasca in Psychiatry in the 21st century | Mário Simões, José Palma |
| Pharmacology of Ayahuasca | Olga Silva |
| Ayahuasca Uncertain Legal Status | Sofia Machado Ferreira |
| A sociological study on alcohol and cannabis use among young people in Spain | Gerardo Flórez Menéndez |
| Socidrogalcohol Spanish national survey on prevalence and treatment of co-ocurrence of substance use disorder and other mental disorder | Juan José Fernández Miranda |
| The RINCA Study On the Reduction of Negative Consequences associated with heavy drinking | Josep Guardia-Serecigni |
| Title of presentation | Author |
|---|---|
| School-Based Drug Use Prevention Multicomponent Model: a Lisbon and Tagus Valley Region Perspective | Isabel Prata |
| Me and the Others Program: Building Standards-based narratives for prevention | Raul Melo |
| ‘Me and Others’ Programme – Outcome Evaluation: Lisbon and Tagus Valley Region sample (2015 to 2017). Pre, post and follow up | Carla Frazao |
| Guidelines to deal with addictive behaviours’. Project, process and outcome evaluation | Rui Pedro Silva |
| Title of presentation | Author |
|---|---|
| Why is a common training curriculum for Europe needed? | Annemie Coone |
| Substance use prevention training needs found in the involved countries and local prevention training needs of the participants. | Annemie Coone |
| Title of presentation | Author |
|---|---|
| The German Registry of EBP: “Green List Prevention” Experiences With Practice | Frederick Groeger-Roth |
| Reviewing and rating EBPs for crime and drugs prevention in Europe: approach and methodological challenges | Nick Axford |
| How Can "Such" Registries Improve Resource Allocation in Prevention | Zili Sloboda |
| Title of presentation | Author |
|---|---|
| Anonymous collecting and testing of NPS samples as a part of national EWS: advantages and challenges | Andreja Drev |
| Establishment of NGO info points for NPS sample collection within regional EWS in the framework of I-SEE project | Ada Hočevar Grom |
| The integrated drug checking service and its importance for different types of users | Simona Šabić |
| Title of presentation | Author |
|---|---|
| Investigating possible causal effects of tobacco and/or cannabis use with mental health: A Mendelian randomisation analysis | Meg Fluharty |
| Drug-related Predictors Of Schizophrenia Readmission | Kristine Rømer Thomsen |
| Gender Differences In Lifetime Psychiatric And Substance Use Disorders Among People Who Use Substances In Barcelona | Gail Gilchrist |
| Alcohol- and drug-related problems among adolescents with psychiatric diagnoses: The role of psychiatric comorbidity. | Ove Heradstveit |
| Father Involvement And Correlates Of Symptoms Of Depression And Anxiety Among Fathers With Drug Addiction Problems | João Barrocas |
| Title of presentation | Author |
|---|---|
| The European Drug Emergencies Network Euro-DEN Plus A model for data collection on acute drug and NPS toxicity in Europe | Paul Dargan |
| The analysis of illicit drugs in Sydney wastewater | Anne Bannwarth |
| Wastewater analysis: source of information about the relation between frequently abused illicit drugs and music genre preferences | Paula Brandeburová |
| Teenagers and NPS in Poland – attitudes and behaviors | Tomasz Białas |
| Title of presentation | Author |
|---|---|
| The normalisation of gambling | Samantha Thomas |
| How Do Gambling Products Which Are Provided In ‘Family Friendly’ Venues, Shape Young People’s Gambling Consumption Intentions? A Qualitative Study Of Children In Australia | Amy Bestman |
| Females with gambling disorder: characteristics and obstacles for treatment | Andrea Wöhr |
| Online sports betting advertising and gambling disorder: a content analysis approach | Hibai Lopez-Gonzalez |
| Strategies And Tactics Used By The Australian Gambling Industry | Samantha Thomas |
| Stigma And The Involvement Of People With Gambling Problems In Peer Support And Advocacy Activities | Helen Miller |
| Parents, Peers, Or Promotion? Which Factors Are The Most Influential In Shaping Children’s Attitudes Towards Gambling? | Hannah Pitt |
| Jegspiller.no – a new prevention tool for problems related to gambling and gaming | Camilla Lynne Bakkeng |
| Title of presentation | Author |
|---|---|
| Chemsex, NPS and risk reduction management- Preliminary results of a pilot study - | Cécile Chevallier |
| Harm Reduction 24/7: The supply of harm reduction materials via vending machines for drug users in North Rhine-Westphalia, Germany. | Daniel Deimel |
| Disciplining pleasure through harm reduction policy: confronting drug users’ personal experience of injection in context with professionals'’ public health expectations | Marie Jauffret- Roustide |
| Title of presentation | Author |
|---|---|
| Social representations of drugs and drug abuse. Inquiry to the Portuguese youth present in three editions of Rock in Rio summer festival (2008/2012/2016) | Vasco Calado |
| The project STOP-SV – a prevention challenge to prevent and combat sexual violence in the nightlife context | Fernando Mendes |
| A randomized trial of assessment interventions to reduce drug use and HIV/STI sexual risk among young adults who use drugs in the club scene | Mance E. Buttram |
| XTC harm reduction strategies @Netherlands | Peggy van der Pol |
| Health consequences of substance use in nightlife settings in the Netherlands | Karin Monshouwer |
| Title of presentation | Author |
|---|---|
| Personalizing and Optimizing Preventive Intervention Models Via a Translational Neuroscience Framework | Diana Fishbein |
| A Translational Neuroscience Framework—Implications for Understanding Etiology and Prevention of Substance Use and Substance Use Disorders | Zili Sloboda |
| Etiology of substance use: implications for treatment | Alessandro Pirona |
| Re-conceptualizing the Aetiology of Substance Use Disorders:Implications for Prevention and Treatment | Gilberto Gerra |
| Title of presentation | Author |
|---|---|
| Access to HCV treatment under special consideration in prison | Gabriele Fischer |
| Joint guidance on prevention and control of communicable diseases in prison settings | Lara Tavoschi |
| Drug use and drug-related infections among prisoners in Europe | Linda Montanari |
| Access to harm reduction – the example of France The ANRS-PRIDE Program | Laurent Michel |
| Access to HCV treatment under special consideration in prison | Gabriele Fischer |
| Title of presentation | Author |
|---|---|
| Establishing an integrated perinatal care program for substance-dependent young mothers | Ulrich Zimmermann |
| The Psychosocial Situation of Children from Methamphetamine-Involved Families | Michael Klein |
| Parenting stress and familial coping in the context of methamphetamine use | Janina Dyba |
| SHIFT – A parenting intervention for methamphetamine abusing mothers and fathers | Diana Moesgen |
| Treatment of methamphetamine addicts in the clinical practice in Germany | Katharina Schoett |
Side events and networking
LxAddictions17 will again provide a unique networking opportunity for researchers, practitioners and policy experts across countries and disciplines, addressing new challenges and covering developing fields. In the margins of the conference various major events will take place. Already confirmed are the following:
- 23 October 2017:
- Third international symposium on drugs and driving (organised in cooperation between CCSA and EMCDDA) – Registration now closed
- 8th MedSPAD committee meeting (closed event organised by the Pompidou Group)
- 7th Symposium of the Alcohol Policy Network Europe (APN), 9:00 to 17:30. Registration now closed
- Monitoring of national policies related to alcohol consumption and harm reduction (closed meeting organised by the World Health Organization Regional Office for Europe and the European Commission)
- Treating Hepatitis C in People Who Use Drugs, Workshop led by INHSU – Registration now closed
- BAONPS - Final Seminar: New findings on NPS and innovations on drug checking services
- 24-25 October 2017
- TWIST — Training With Stakeholders – applying EU drug research: The EC-funded TWIST project will provide a two-day training programme, aimed at early-stage addiction professionals, embedded within the scope and programme of LxAddictions17.
- 26-27 October 2017
- Third testing the waters conference (organised in cooperation between SCORE and EMCDDA) – Registration now closed
Please note that participants need to register separately for side‑events.
To promote networking, conference rooms will be available for side events. If interested please contact us at: lisbonaddictions2017@abreu.pt
Sponsored sessions
These are open sessions, no separate registration is required.
- 25 October
- COPOLAD – Next challenges for Drugs Observatories in providing information relevant for evidence based policy making (12:45–14:15, Auditorium III)
- ERANID – Results of ERANID, its Strategic Research Agenda and projects (12:45–14:15, Room 5A)
- RAHRA – Member States work together on Reducing Alcohol Related Harm (12:45–14:15, Room 5B)
- 26 October 2017
- MERCK SHARP & DOME – The importance of treating HCV in people who inject drugs (12:45–14:15, Room 1.07)
Registration – Now closed
Please note that Lisbon has become a popular location for many congresses and other major events. We strongly advise you to book your hotel well in advance by contacting the Local Management Company.
Looking for tips on exploring Lisbon and nearby destinations? Our local partners have arranged for a tour organising company to be on site at LxAddictions17, but you may already select and book your tours and visits at Cityrama.
Exhibitors
Place of exhibition
CCL - CENTRO DE CONGRESSOS DE LISBOA
Praça das Indústrias
1300-307 Lisbon
Portugal
LOCAL EXHIBITION MANAGEMENT COMPANY
ABREU-PCO
Avenida 25 de Abril, 2
2799-556 Linda-a-Velha
Portugal
Please contact the local exhibition management company to receive further information about the exhibition (set-up, dismantling, stands, furniture, terms & conditions, order forms, etc.)
Organisers and partners
Organisers
International organisations
.gif)
Collaborative partners
.gif){kind=logo}
Supporting organisations
- Judith Aldridge (Senior Lecturer, School of Law, University of Manchester, UK)
- Hannu Alho (ISAM President, Professor of Addiction Medicine, Finland)
- Alexander Baldacchino (Professor of Medicine, Psychiatry and Addictions, University of St Andrews, UK)
- Henri Bergeron (Chair in Health Studies, Sciences Po Paris, France)
- Virginia Berridge (Professor of History and Director, Centre for History in Public Health, London School of Hygiene and Tropical Medicine, UK)
- Kim Bloomfield (Professor, Center for Alcohol and Drug Research, Aarhus University, Denmark)
- Henrietta Bowden-Jones (Consultant Psychiatrist. Founder and Director, National Problem Gambling Clinic, UK)
- Jørgen G. Bramness (Senior researcher, Norwegian National Advisory Unit on Concurrent Substance Abuse and Mental Health Disorders, Norwegian Centre of Dual Diagnosis)
- Anne Line Bretteville-Jensen (Research Director, Norwegian Institute for Alcohol and Drug Research (SIRUS), Norway)
- Angelina Brotherhood (Public Health Researcher, Liverpool John Moores University, UK)
- Gerhard Bühringer (Chair of Addiction Research, Institute for Clinical Psychology and Psychotherapy, Technische Universität Dresden, Germany)
- Catherine Comiskey (Head of School of Nursing and Midwifery, Trinity College, Ireland)
- Ornella Corazza (Reader in Substance Addictions and Behaviours, University of Hertfordshire, Hatfield, UK)
- Paul Dargan (Consultant Physician and Clinical Toxicologist, Guy's and St Thomas' NHS Foundation Trust, and Reader in Toxicology, King’s College London, UK)
- Marina Davoli (Head, Department of Epidemiology, National Agency for Health Services, Italy)
- Louisa Degenhardt (Professor, National Drug and Alcohol Research Centre (NDARC), Australia)
- Fernando Rodríguez de Fonseca (Fundación IMABIS, Hosp. Univ. Carlos Haya de Málaga, Spain)
- Brice de Ruyver (Full Professor criminal law and criminology, Director Institute for International Research on Criminal Policy, Ghent University, Belgium)
- Fabrizio Faggiano (Professor of Public Health at the Department of Translational Medicine of the University of the Piemonte Orientale, Italy)
- Michael Farrell (Director, National Drug and Alcohol Research Centre (NDARC), University of New South Wales, Australia)
- Gabriele Fischer (Medical Director of the Addiction Clinic at the Medical University Vienna, Austria)
- Henk Garretsen (Professor, Director Tranzo, Scientific Centre for Care and Welfare, Tilburg University, The Netherlands)
- Eilish Gilvarry (President of the Society for the Study of Addiction, Honorary Professor of Addiction Psychiatry, Newcastle University, UK)
- Manuela Grazina (Professor, Faculty of Medicine; Researcher and Head of Laboratory of Biochemical Genetics, Center for Neuroscience and Cell Biology; University of Coimbra, Portugal)
- Antoni Gual (Director of the Addictions Unit, Hospital Clínic Barcelona, Spain)
- Wayne Hall (Professor, Director and Inaugural Chair, Centre for Youth Substance Abuse Research, The University of Queensland, Australia)
- Matthew Hickman (School of Social and Community Medicine, University of Bristol, UK)
- Susana Jiménez-Murcia (Head of Pathological Gambling Unit, Department of Psychiatry, University Hospital of Bellvitge, Barcelona, Spain)
- Beau Kilmer (Co-director and senior policy researcher, RAND Drug Policy Research Center; Professor, Pardee RAND Graduate School, USA)
- Dirk Korf (Professor, Bonger Institute of Criminology, University of Amsterdam, The Netherlands)
- Krzysztof Krajewski (Chair of Criminology, Jagiellonian University, Poland)
- Ludwig Kraus (Director, IFT Institut für Therapieforschung, Munich, Germany)
- Håkan Leifman (Director, Swedish Council for Information on Alcohol and Other Drugs (CAN), Sweden)
- Henrique Lopes (President of the Ibero-latin-american Scientific Society for Gambling Research, Chair of CEIA research center, researcher at Public Healthcare Unit of Catholic University - ICS)
- Pia Mäkelä (Head of Alcohol and Drugs Unit, National Institute for Health and Welfare, Finland)
- Meni Malliori (Associate Professor of Psychiatry, Medical School, National & Kapodistrian University of Athens, Greece)
- Rebecca McKetin (Associate Professor, ANU College of Medicine, Biology and Environment, Australia)
- Angela Me (Chief of the Research and and Trend Analysis Branch, United Nations Office on Drugs and Crime)
- Lars Møller (Programme Manager Alcohol & Illicit Drugs and Prison Health, World Health Organization Regional Office for Europe)
- Catherine Moury (Assistant Professor of political Science, FCSH, Universidade Nova de Lisboa, Portugal)
- Emília Nunes (Professor, Director of the National Programme for Prevention of Smoking and Tobacco Control, General-Directorate of Health, Portugal)
- Letizia Paoli (Professor, Leuven Institute of Criminology, University of Leuven, Faculty of Law, Belgium)
- Amy Porath-Waller (Director, Research and Policy, Canadian Centre on Substance Abuse, Canada)
- Jürgen Rehm (Director, Social and Epidemiological Research (SER) Department, Centre for Addiction and Mental Health, Toronto, Canada)
- Xavier Majó i Roca (Office of Drug Addiction, Public Health Agency of Catalonia, Spain)
- Zila M. Sanchez (Professor of Epidemiology, Preventive Medicine Department, Universidade Federal de São Paulo, Brazil)
- Emanuele Scafato (Director of Population’s Health and Health Determinants Unit in the National Centre for Epidemiology, Surveillance and Health Promotion-CNESPS at the Istituto Superiore di Sanità, Italy)
- Janusz Sieroslawski (Institute of Psychiatry and Neurology, Poland)
- Jussi Simpura (Chair, Finnish Foundation for Alcohol Studies)
- Zili Sloboda (President, Applied Prevention Science, Inc., USA)
- Rainer Spanagel (Professor of Pharmacology & Toxicology, Head of the Institute of Psychopharmacology, University of Heidelberg, Germany)
- Kerstin Stenius (Ass. Prof., Centre for Social Research on Alcohol and Drugs, Stockholm University, Sweden; Alcohol and Drugs unit, National Institute for Health and Welfare, Finland; and Nordic Centre for Welfare and Social Issues, Finland)
- John Strang (Professor, Head of the Addictions Department, Institute of Psychiatry, Psychology & Neuroscience (IoPPN), King’s College London, UK)
- Harry Sumnall (Professor, Centre for Public Health, Liverpool John Moores University, UK)
- Margriet Van Laar (Head of the Department Drug Monitoring, Trimbos Institute, The Netherlands)
- Julian Vicente (Head of the prevalence, consequences and data management unit, EMCDDA)
- Graça Vilar (Director of the Planning and Intervention Department of SICAD, Master in forensic medicine and forensic sciences, Graduate Assistant of Psychiatry Hospital, Portugal)
- Chris Wilkins (Senior Researcher, Drugs Team Leader, SHORE & Whariki Research Centre, College of Health, Massey University, Auckland, New Zealand)
Co-chairs: Manuel Cardoso (SICAD), Paul Griffiths (EMCDDA)
- Robert West (Addiction/Society for the Study of Addiction)
- Ann McNeill (Addiction/Society for the Study of Addiction)
- Richard Pates (ISAJE)
- Michal Miovsky (ISAJE)
- Ana Sofia Santos (SICAD)
- Ana Rodrigues (SICAD)
- Maria Moreira (EMCDDA)
- Liesbeth Vandam (EMCDDA)
- Manuel Cardoso (SICAD)
- Ana Sofia Santos (SICAD)
- Ana Rodrigues (SICAD)
- Filipa Cunha (SICAD)
- Sónia Ferreira (SICAD)
- Alexandra Pinto (SICAD)
- Paul Griffiths (EMCDDA)
- Maria Moreira (EMCDDA)
- Liesbeth Vandam (EMCDDA)
- Marie-Christine Ashby (EMCDDA)
- Silke Vitt (EMCDDA)
- Renate Hochwieser (EMCDDA)
- Prem Borle (EMCDDA)
- Alberto Oteo